SCHEMBL5453836

SCHEMBL5453836

Cc1cc(NC(=O)C(CCCCNS(N)(=O)=O)NC(=O)O)c2ccccc2n1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 16/20 0.51
HDAC1 Q13547 13/20 0.51
HDAC3 O15379 11/20 0.51
HDAC4 P56524 11/20 0.51
HDAC7 Q8WUI4 11/20 0.51
HDAC2 Q92769 11/20 0.51
HDAC10 Q969S8 11/20 0.51
HDAC11 Q96DB2 11/20 0.51
HDAC8 Q9BY41 11/20 0.51
HDAC9 Q9UKV0 11/20 0.51
HDAC5 Q9UQL6 11/20 0.51
HTT P42858 2/20 0.47
GALR3 O60755 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8107044 0.89 HDAC6 (0.67) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5459383 0.81 HDAC6 (0.59) HDAC6HDAC1HDAC3HTTGALR3
SCHEMBL5451717 0.79 HDAC6 (0.62) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5464542 0.79 HDAC6 (0.64) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5461892 0.78 HDAC6 (0.77) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5457369 0.77 HDAC6 (0.51) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5455396 0.76 HDAC6 (0.64) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5466535 0.76 HDAC6 (0.64) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5327667 0.74 HDAC6 (0.82) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5484115 0.74 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC6 11/4885HDAC1 1/4885HDAC3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.